Alzheimer’s disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank - Scorecard - MDSpire

Alzheimer’s disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank

  • By

  • Junming Hu

  • Simon Lu

  • Qi Zhang

  • Kehan Qian

  • Habbiburr Rehman

  • Congcong Zhu

  • John Farrell

  • Julio E Castrillon-Candas

  • Rhoda Au

  • Lindsay A Farrer

  • Wei Q Qiu

  • Jinying Chen

  • Xiaoling Zhang

  • June 1, 2026

  • 0 min

Share

Clinical Scorecard: Predicting Alzheimer’s Disease Risk Through Clinical and Social Health Factors: A Machine Learning Analysis Using UK Biobank Data

At a Glance

CategoryDetail
ConditionAlzheimer’s Disease (AD)
Key MechanismsIntegration of clinical, genetic, and social determinants of health (SDOH) for risk prediction.
Target PopulationIndividuals aged 50 and older, specifically those at risk for late-onset AD.
Care SettingPrimary care and epidemiological studies.

Key Highlights

  • Automated machine learning pipeline developed using UK Biobank data.
  • Age and APOE genotype are strong predictors of AD risk.
  • Social determinants of health significantly contribute to AD risk prediction.
  • Routine health and social data can facilitate scalable AD risk screening.
  • Study emphasizes the need for integrating diverse predictors in dementia risk models.

Guideline-Based Recommendations

Diagnosis

  • Utilize a combination of clinical measures and social determinants for comprehensive risk assessment.

Management

  • Incorporate routinely collected health and social data into risk prediction models.

Monitoring & Follow-up

  • Regularly assess risk factors over time to identify individuals at higher risk for AD.

Risks

  • Consider the limitations of current biomarkers and the need for cost-effective screening tools.

Patient & Prescribing Data

Individuals aged 50 and older without prior AD diagnosis.

Focus on early detection through scalable risk assessment methods.

Clinical Best Practices

  • Employ automated feature selection methods to enhance model accuracy.
  • Validate risk prediction models with clinical expertise.
  • Integrate diverse clinical and social factors for a holistic approach to AD risk.

Related Resources & Content

Original Source(s)

Alzheimer’s disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank

  • by Junming Hu, Simon Lu, Qi Zhang, Kehan Qian, Habbiburr Rehman, Congcong Zhu, John Farrell, Julio E Castrillon-Candas, Rhoda Au, Lindsay A Farrer, Wei Q Qiu, Jinying Chen, Xiaoling Zhang

  • June 1, 2026

Related Content

Agitation, Alzheimer’s disease, and autophagy: mechanistic insights into aging pathways, gut microbiome, and artificial intelligence

I’m an Alzheimer’s specialist. I still missed it in my own father

Acceptability of Technologies to Support Early Dementia Detection: Qualitative Study With the Boston University Alzheimer’s Disease Center Cohort